Silicon Laboratories Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Silicon Laboratories heeft een totaal eigen vermogen van $1.1B en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $1.2B en $167.9M.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$369.68m |
| Aandelen | US$1.08b |
| Totaal verplichtingen | US$167.86m |
| Totaal activa | US$1.25b |
Recente financiële gezondheidsupdates
Health Check: How Prudently Does Silicon Laboratories (NASDAQ:SLAB) Use Debt?
Feb 19
Is Silicon Laboratories (NASDAQ:SLAB) A Risky Investment?
Nov 02Here's Why Silicon Laboratories (NASDAQ:SLAB) Can Manage Its Debt Responsibly
Jul 10Is Silicon Laboratories (NASDAQ:SLAB) Using Too Much Debt?
Apr 10Silicon Laboratories (NASDAQ:SLAB) Seems To Use Debt Quite Sensibly
Dec 19Recent updates
A Slower, More Stretched-Out Recovery Has Weighed On Silicon Labs
Nov 05Pinning Down Silicon Laboratories Inc.'s (NASDAQ:SLAB) P/S Is Difficult Right Now
Nov 01Silicon Laboratories: A Questionable Outlook Offsets Improving Results
Oct 17Silicon Laboratories: Equity Story Remains Very Attractive
Jul 31Silicon Labs Ready For The Next IoT-Fueled Run
Jul 14Investor Optimism Abounds Silicon Laboratories Inc. (NASDAQ:SLAB) But Growth Is Lacking
Jul 11Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Could Be 31% Below Their Intrinsic Value Estimate
Jun 20Silicon Laboratories: An Uncertain Recovery Outlook Continues To Linger
May 05We Think Some Shareholders May Hesitate To Increase Silicon Laboratories Inc.'s (NASDAQ:SLAB) CEO Compensation
Apr 13Silicon Laboratories Inc.'s (NASDAQ:SLAB) Business Is Trailing The Industry But Its Shares Aren't
Mar 26Health Check: How Prudently Does Silicon Laboratories (NASDAQ:SLAB) Use Debt?
Feb 19Silicon Laboratories: Upgrade To Neutral As Near-Term Bear Case Is In Focus
Feb 11Are Investors Undervaluing Silicon Laboratories Inc. (NASDAQ:SLAB) By 31%?
Feb 01Silicon Laboratories: Why The Stock Could Be Heading Lower
Jan 30At US$132, Is It Time To Put Silicon Laboratories Inc. (NASDAQ:SLAB) On Your Watch List?
Jan 02Silicon Laboratories Inc. (NASDAQ:SLAB) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Dec 18Is Silicon Laboratories (NASDAQ:SLAB) A Risky Investment?
Nov 02Is It Time To Consider Buying Silicon Laboratories Inc. (NASDAQ:SLAB)?
Sep 29A Look At The Fair Value Of Silicon Laboratories Inc. (NASDAQ:SLAB)
Sep 11Silicon Laboratories Inc. (NASDAQ:SLAB) Analysts Just Slashed This Year's Revenue Estimates By 11%
Aug 04Is Now The Time To Put Silicon Laboratories (NASDAQ:SLAB) On Your Watchlist?
Jul 28Here's Why Silicon Laboratories (NASDAQ:SLAB) Can Manage Its Debt Responsibly
Jul 10Is It Time To Consider Buying Silicon Laboratories Inc. (NASDAQ:SLAB)?
May 29Is Silicon Laboratories (NASDAQ:SLAB) Using Too Much Debt?
Apr 10Is It Time To Consider Buying Silicon Laboratories Inc. (NASDAQ:SLAB)?
Feb 13Silicon Laboratories (NASDAQ:SLAB) Seems To Use Debt Quite Sensibly
Dec 19What Is Silicon Laboratories Inc.'s (NASDAQ:SLAB) Share Price Doing?
Oct 17Silicon Laboratories Is Nearing An Important Junction (Technical Analysis)
Sep 26An Intrinsic Calculation For Silicon Laboratories Inc. (NASDAQ:SLAB) Suggests It's 27% Undervalued
Sep 26Silicon Labs' board authorizes additional $200M share repurchase
Aug 29Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $614.1M ) SLAB } overtreffen de korte termijn passiva ( $118.3M ).
Langlopende schulden: De kortetermijnactiva SLAB ( $614.1M ) overtreffen de langetermijnschulden ( $49.6M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: SLAB is schuldenvrij.
Schuld verminderen: SLAB heeft geen schulden vergeleken met 5 jaar geleden, toen de schuld/eigen vermogen-ratio 33.7% was.
Schuldendekking: SLAB heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.
Rentedekking: SLAB heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.